News

Latest News:

MC2 Biotek becomes MC2 Therapeutics

POSTED: December 15, 2016

MC2 Biotek, a clinical stage emerging specialty pharmaceutical company focusing on dermatology and ophthalmology, today announced that it has changed its name to MC2 Therapeutics.

Jesper J. Lange, President of MC2 ...

READ FULL ARTICLE >

EMA Paediatric Committee (PDCO) granted a waiver for MC2-03 PAD ™ Eye Drop

POSTED: September 29, 2016

Acceptance of this waiver for the Paediatric Investigation Plan (PIP) paves the way for the potential submission of a Marketing Authorization Application (MAA) in Europe following completion of the ongoing ...

READ FULL ARTICLE >

MC2 Biotek to present at ARVO

POSTED: May 1, 2016

MC2 Biotek, a clinical stage specialty pharmaceutical company focused on the development and commercialization of topical drugs that addresses the major problem of non-compliance of otherwise highly efficacious ...

READ FULL ARTICLE >

Events:

May 12th - 14th, 2024

MC2 Therapeutics to present at the 24th Bio€quity Europe

READ MORE >

February 28th - 29th, 2024

MC2 Therapeutics to present at the 17th Annual European Life Sciences CEO Forum

READ MORE >

November 14th - 16th, 2023

Meet MC2 at Jefferies London Healthcare Conference

READ MORE >

May 15th - 16th, 2023

MC2 Therapeutics to present at Bio€quity Europe 2023

READ MORE >

February 7th, 2023

MC2 Therapeutics to present at the BIO CEO & Investor Conference in NYC

READ MORE >

January 9th - 12th, 2023

J.P. Morgan Healthcare Conference 2023 (San Francisco)

READ MORE >

January 8th, 2023

MC2 Therapeutics to present at the Dermatology Summit 2023 in San Francisco

READ MORE >

December 7th, 2022

MC2 Therapeutics to present at Carnegie’s Next Generation Nordic Life Science Champions Seminar 2022

READ MORE >

November 15th - 17th, 2022

MC2 Therapeutics attends the Jefferies London Healthcare Conference

READ MORE >

February 28th, 2022

MC2 exposure at PCMA Business Forum 2022

READ MORE >

August 11th, 2021

MC2 Therapeutics is proud to support National Psoriasis Action Month

READ MORE >

July 23, 2021

MC2 Therapeutics supports World Sjögren’s Day

READ MORE >